
Feature
The Post-Election Boardroom
By Alexandra R. Lajoux
Six scenarios that boards should consider to prepare for potential regulatory changes after the November US election.
Governance Surveys
Photo Credit: iStockphoto / Maisel
Feature
In 2007, Israeli national security officials told their American counterparts about a building being constructed at Al Kibar in Syria, Micah Zenko writes in his book, Red Team: How to Succeed by Thinking Like the Enemy. The Israelis feared that it was a nuclear reactor, similar to one developed by the North Koreans...
Jeff Kindler, CEO of Centrexion Corp., a privately held biotherapeutics company, previously served as chair and CEO of Pfizer. He is a senior advisor for Blackstone, a member of the boards of several public and private organizations, and a principal in and advisor to a number of health-care firms and sponsors.
Thank you for your interest in this page.
Explore All Directorship Issues